
GMAB
USDGenmab A/S ADS
即時價格
價格圖表
關鍵指標
市場指標
開盤
$28.540
最高
$29.390
最低
$28.510
交易量
2.92M
公司基本面
市值
17.8B
行業
生物科技
國家
Denmark
交易統計
平均交易量
2.00M
交易所
NMS
貨幣
USD
52週範圍
相關新聞
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
More than 20 abstracts, including seven oral presentations, highlight advancements from the epcoritamab development program supporting the expanded clinical profile and potential of epcoritamab for a broader range of
HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Genmab with a Buy and maintains $40 price target.
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025
Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech,
相關股票
XOMAO
XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
THRD
Third Harmonic Bio Inc.
BJDX
Bluejay Diagnostics Inc.
LIQT
LiqTech International Inc.
SLS
SELLAS Life Sciences Group Inc.
保持更新
設定價格提醒,獲取AI分析更新和即時市場新聞。